NCT02073448 - Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris. | Biotech Hunter

Enrollment

417

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Acne Vulgaris

Interventions

DRUG

GK530G

DRUG

CD0271

DRUG

CD1579

Trial Locations (13)

Galderma investigational site, Chitose

Galderma investigational site, Kitami

Galderma investigational site, Sapporo

Galderma investigational site, Kagoshima

Galderma investigational site, Yokohama

Galderma investigational site, Kurashiki

Galderma investigational site, Daitō

Galderma investigational site, Neyagawa

Galderma investigational site, Osaka

Galderma investigational site, Sakai

Galderma investigational site, Saitama

Galderma investigational site, Adachi City

Galderma investigational site, Setagaya City